School of Medicine Publications and Presentations
Document Type
Article
Publication Date
11-4-2022
Abstract
There is increasing evidence suggesting the role of microbiome alterations in relation to pancreatic adenocarcinoma and tumor immune functionality. However, molecular mechanisms of the interplay between microbiome signatures and/or their metabolites in pancreatic tumor immunosurveillance are not well understood. We have identified that a probiotic strain (Lactobacillus casei) derived siderophore (ferrichrome) efficiently reprograms tumor-associated macrophages (TAMs) and increases CD8 + T cell infiltration into tumors that paralleled a marked reduction in tumor burden in a syngeneic mouse model of pancreatic cancer. Interestingly, this altered immune response improved anti-PD-L1 therapy that suggests promise of a novel combination (ferrichrome and immune checkpoint inhibitors) therapy for pancreatic cancer treatment. Mechanistically, ferrichrome induced TAMs polarization via activation of the TLR4 pathway that represses the expression of iron export protein ferroportin (FPN1) in macrophages. This study describes a novel probiotic based molecular mechanism that can effectively induce anti-tumor immunosurveillance and improve immune checkpoint inhibitors therapy response in pancreatic cancer.
Recommended Citation
Chaib, M., Hafeez, B.B., Mandil, H. et al. Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. Commun Biol 5, 1181 (2022). https://doi.org/10.1038/s42003-022-04102-4
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publication Title
Commun Biol
DOI
10.1038/s42003-022-04102-4
Academic Level
faculty
Mentor/PI Department
Immunology and Microbiology
Comments
Copyright © 2022, The Author(s)